Drug Shortage Report for SANDOZ ATORVASTATIN

Last updated on 2020-01-22 History
Report ID 99333
Drug Identification Number 02324946
Brand name SANDOZ ATORVASTATIN
Common or Proper name ATORVASTATIN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) ATORVASTATIN
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 3X10 Bl
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-11-29
Actual start date
Estimated end date 2020-01-27
Actual end date 2020-01-10
Shortage status Resolved
Updated date 2020-01-22
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-01-22 French Compare
v6 2020-01-22 English Compare
v5 2019-11-30 English Compare
v4 2019-11-20 French Compare
v3 2019-11-20 English Compare
v2 2019-11-20 French Compare
v1 2019-11-20 English Compare